This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Secretary of. Active years: 1987.
Company Filing History:
Years Active: 1987
Title: Eli Heldman: Innovator in Hemophilia Treatment
Introduction
Eli Heldman is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of medical science, particularly in the treatment of hemophilia. His innovative work has led to the development of a new line of endothelial cells that have the potential to improve patient outcomes.
Latest Patents
Eli Heldman holds 1 patent for his invention titled "Isolation and culture of adrenal medullary endothelial cells producing." This patent discloses a new line of endothelial cells of adrenal medullary origin capable of producing blood clotting Factor VIII:C. The method of isolating and culturing this cell line has also been detailed in the patent. Factor VIII:C is crucial for treating hemophilia, making this invention particularly valuable in the medical field.
Career Highlights
Eli Heldman works for the United States of America as Represented by the Secretary of Health and Human Services. His role involves significant research and development efforts aimed at advancing medical treatments and technologies. His dedication to innovation has positioned him as a key figure in his field.
Collaborations
Eli has collaborated with esteemed colleagues such as Harvey B Pollard and Richard Ornberg. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Eli Heldman's contributions to the field of hemophilia treatment through his innovative patent demonstrate his commitment to advancing medical science. His work not only showcases his inventiveness but also highlights the importance of collaboration in achieving significant breakthroughs.